Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Massachusetts for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Massachusetts only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Massachusetts (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Stacey Godman (NPI 1689902595)

Field	Value
Entity Type	Individual
Organization	Stacey Godman
Address	12 Gill St
City	Woburn
State	MA
ZIP	01801
Taxonomy	Nurse Practitioner
NPI Enumerated	December 4, 2009

Payer Source	Total Paid
Medicare	$1.7M
Medicaid	$0

Key Findings

This provider's billing is effectively single‑payer Medicare: total Medicare revenue is $1.7M while there is no Medicaid billing on file, indicating the practice derives its billable activity to Medicare beneficiaries almost exclusively. Analysts should treat Medicaid-related competitive and utilization inferences as inapplicable for this NPI.

Revenue is highly concentrated in a small set of drugs: the precomputed top 3 Medicare codes (J3245, J0517, J1306) account for 81.6% of the provider's total Medicare revenue. In particular, J3245 alone represents $1M (62.1% of Medicare revenue), making that single product the primary revenue driver for the practice.

The code mix indicates a specialty outpatient infusion/injection operation that primarily administers high-cost injectable therapies: J3245 (tildrakizumab), J0517 (benralizumab) and multiple other biologic injection codes dominate revenue, while procedure codes such as 96372 and 96365 show in‑office injection/infusion activity. This pattern is consistent with a practice focused on clinic-administered biologic or specialty injectable therapies rather than routine primary care visits.

National competitive standing is particularly strong for J3245: the provider ranks #16 of 225 nationally (93th percentile) and is described as "notably above typical national volume for this code," indicating the practice is a major national participant for tildrakizumab administrations. That high concentration around one product represents both a strength (market niche) and a concentration risk if utilization or coverage for that drug changes.

For the other top medicines the provider is a more modest or typical participant: J0517 (benralizumab) accounts for $199.5K (12.0% of Medicare revenue) and ranks #73 of 200 (63th percentile; typical, unremarkable volume), while J1306 (inclisiran) accounts for $125.2K (7.5% of Medicare revenue) and ranks #116 of 462 (75th percentile; typical, unremarkable volume). These ranks suggest the practice participates meaningfully in multiple specialty injection lines but only one code reaches notably above‑typical volume.

Infusion and chemotherapy-related procedure billing is present but represents a small share of revenue: 96413 generated $11.2K (0.7% of Medicare revenue) and 96372 generated $3.9K (0.2% of Medicare revenue). Ranks on these procedure codes (for example 96413 at #4188 of 7514 and 96372 at #2514 of 58224) and the supplied plain‑English labels (both described as typical, unremarkable volume) indicate the provider supports infusion/administration services but does not derive material revenue from oncologic chemotherapy codes.

The NPI tenure is long-standing — enumerated 2009-12-04 (~17 years ago) — which supports that these prescribing and administration patterns are established rather than transient. For payer strategy and network planning, this longevity plus the concentrated revenue profile around injectable specialty drugs should guide discussions on contract value, specialty drug management, and referral relationships.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

11 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J3245	Injection, tildrakizumab, 1 mg	9,400	$110	$1M
J0517	Injection, benralizumab, 1 mg	1,500	$130	$199.5K
J1306	Injection, inclisiran, 1 mg	13,920	$10	$125.2K
J2182	Injection, mepolizumab, 1 mg	3,900	$20	$89.7K
J2356	Injection, tezepelumab-ekko, 1 mg	5,670	$10	$79.4K
J2357	Injection, omalizumab, 5 mg	2,630	$30	$78.8K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	1,530	$30	$39.8K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	120	$90	$11.2K
96372	A therapeutic, prophylactic, or diagnostic substance (a fluid, a drug, etc.) is injected via intramuscular or subcutaneous route into the patient's body. The procedure is performed by the physician…	390	$10	$3.9K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	80	$50	$3.7K

Showing 1–10 of 11

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 11 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Massachusetts Distribution

Stacey Godman — 1 of 11 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Massachusetts

Full comparison — all codes billed, vs. state median

11 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J3245	2	10	9,400	$110	$799.8K
J2357	7	10	4,430	$30	$294.4K
J0517	4	10	1,500	$130	$291.9K
J2182	2	10	9,750	$20	$226.3K
J1306	1	10	13,920	$10	$130.3K
J1745	13	20	3,920	$30	$119.4K
J2356	1	10	5,670	$10	$81K
96413	31	60	120	$110	$17.6K
96365	31	110	50	$50	$4.8K
96415	35	50	90	$20	$3.2K

Showing 1–10 of 11

Related Providers

Other providers that share a Tax Identification Number (TIN) with Stacey Godman, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Danielle Young	PA	Family Nurse Practitioner	$3.7M	$0
Caitlin Trainor	PA	Family Nurse Practitioner	$1.3M	$0
Priti Patel	PA	Family Nurse Practitioner	$900.3K	$0
Danielle Boyle	PA	Family Nurse Practitioner	$411.3K	$0
Jeanne-marie Firpo	NY	Nurse Practitioner	$210.9K	$0
Prasant Pandey	PA	Cardiovascular Disease Physician	$122.3K	$0

Nearby Providers

Other providers in the same ZIP code as Stacey Godman, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Hri Clinics, Inc.	MA	Community/Behavioral Health Agency	$0	$101.5M
Diligent Personal Care, Inc	MA	Adult Care Home Facility	$0	$50.3M
Compassionate Care Hospice Of Massachusetts, LLC	MA	Community Based Hospice Care Agency	$0	$31.7M
New England Home Health Services, Inc.	MA	Home Health Agency	$0	$28M
A Joyful Adult Health Care Center LLC	MA	Adult Day Care Clinic/Center	$0	$19.2M
Quality Care	MA	In Home Supportive Care Agency	$0	$18.3M
New England Life Care, Inc.	MA	Home Infusion Therapy Pharmacy	$20.9K	$11.6M
Alliance Home Care Visiting Nurse Agency, Inc.	MA	Home Health Agency	$0	$11M
Nupath Inc	MA	Developmentally Disabled Services Day Training Agency	$0	$9.4M
Communitas, Inc.	MA	Developmentally Disabled Services Day Training Agency	$0	$7.4M

Stacey Godman — Billing Profile & Reimbursement Data

Sign up for Stacey Godman — Billing Profile & Reimbursement Data policy alerts

Stacey Godman — Billing Profile & Reimbursement Data

Sign up for Stacey Godman — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References